|
SDCBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.70450370168874E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.10739989295428E-10 |
| Normal-vs-Stage2 |
4.70570005184356E-09 |
| Normal-vs-Stage3 |
1.24690036074071E-10 |
| Normal-vs-Stage4 |
5.5211391014609E-13 |
| Stage1-vs-Stage2 |
9.248000E-01 |
| Stage1-vs-Stage3 |
5.321600E-01 |
| Stage1-vs-Stage4 |
5.076000E-03 |
| Stage2-vs-Stage3 |
7.329400E-01 |
| Stage2-vs-Stage4 |
5.330300E-02 |
| Stage3-vs-Stage4 |
4.312200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.42269973579801E-10 |
| Normal-vs-AfricanAmerican |
7.91920000000612E-05 |
| Normal-vs-Asian |
7.65820740156187E-12 |
| Caucasian-vs-AfricanAmerican |
4.373000E-01 |
| Caucasian-vs-Asian |
1.062040E-01 |
| AfricanAmerican-vs-Asian |
1.186610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.15867340564091E-12 |
| Normal-vs-Female |
9.5528029930847E-11 |
| Male-vs-Female |
8.698000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.25229826508644E-11 |
| Normal-vs-Age(41-60Yrs) |
2.50479637031731E-11 |
| Normal-vs-Age(61-80Yrs) |
3.54200002661287E-10 |
| Normal-vs-Age(81-100Yrs) |
3.861400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.341000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.266800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.794600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.055800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.688600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.701600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.562600E-01 |
| Classical-VS-Follicular |
5.890000E-01 |
| Classical-VS-Other |
1.152580E-01 |
| Classical-VS-Normal |
8.18379808364966E-11 |
| Tall-VS-Follicular |
8.725400E-01 |
| Tall-VS-Other |
7.238100E-02 |
| Tall-VS-Normal |
3.88749998858628E-09 |
| Follicular-VS-Other |
2.635000E-01 |
| Follicular-VS-Normal |
1.64290003823453E-09 |
| Other-VS-Normal |
7.17150000495437E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.52250459304082E-11 |
| Normal-vs-N1 |
3.81694675866129E-13 |
| N0-vs-N1 |
2.627900E-02 |
|
|
